Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT-P17 vs Humira in Chronic Plaque Psoriasis
NCT05495568Phase 3Completed
- Sponsor
- Celltrion
- Start
- Nov 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of RT-105 in plaque psoriasis, sponsored by Celltrion. Started Nov 2022; status: completed.
02
Drugs
RT-105
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05495568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05495568.